CD8A and neoplasm: As shown in Tables 2, 3, the findings revealed no significant differences in terms of gender, age, maximum lesion diameter, histological type, or tumor stage between the training cohort and validation cohort’s high and low CD3 and CD8 expression levels, and the differences were not statistically significant (all P values > 0.05).